DUKE Robotics Corp.
For the period ended Mar 31, 2026. Filed May 20, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 20, 2026
Contents
Notes to Consolidated Financial Statements
NOTE 1 – GENERAL
| A. | Duke Robotics Corp. (“the Company”) was incorporated under the laws of the State of Nevada on February 4, 2015. |
On March 9, 2020, the Company closed on the Share Exchange Agreement (as defined hereunder), pursuant to which, Duke Robotics, Inc. (“Duke Inc.”) a corporation incorporated under the laws of the state of Delaware, became a majority-owned subsidiary of the Company. Duke Inc. has a wholly-owned subsidiary, Duke Airborne Systems Ltd. (“Duke Israel,” and collectively with Duke Inc., “Duke”), which was formed under the laws of the State of Israel in March 2014 and became the sole subsidiary of Duke after its incorporation.
On April 29, 2020, the Company, Duke Inc., and UAS Acquisition Corp., a Delaware corporation and a wholly-owned subsidiary of the Company (“UAS Sub”), executed an Agreement and Plan of Merger (the “Merger Agreement”), pursuant to which UAS Sub merged with and into Duke Inc., with Duke Inc. surviving as our wholly-owned subsidiary (the “Short-Form Merger”). Upon closing of the Short-Form Merger, each outstanding share of UAS Sub’s common stock, par value $0.0001 per share, was converted into and became one share of common stock of Duke Inc., with Duke Inc. surviving as a wholly-owned subsidiary of the Company.
Following the above transactions, Duke Israel became a wholly-owned subsidiary of Duke Inc., which is a wholly-owned subsidiary of the Company.
On February 18, 2025, the Company established Duke Robotics Hellas M I.K.E (“Duke Greece”), a wholly owned subsidiary, formed under the laws of Greece, to support the ongoing global commercialization efforts of the Company’s Insulator Cleaning (“IC”) Drone system.
The Company (collectively with Duke, the “Group”) is a robotics company dedicated to developing an advanced robotics stabilization system that enables remote, real-time, pinpoint accurate firing of small arms and light weapons as well as other civilian applications, with an emphasis in the field of routine infrastructure maintenance. The Company offers high-voltage insulator washing abilities using its innovative Insulator Cleaning (“IC”) Drone system. This technology provides an efficient and safe method for cleaning high-voltage insulators, improving their performance, enhancing safety, and reducing maintenance costs.
On October 28, 2024, the Company filed a certificate of amendment to its Articles of Incorporation with the Nevada Secretary of State to change the Company’s corporate name from UAS Drone Corp. to DUKE Robotics Corp. effective as of November 4, 2024.
The Company’s common stock, par value $0.0001 per share (the “Common Stock”) was previously quoted on the OTC Markets Group, Inc.’s OTCQB® tier Venture Market, under the symbol “DUKR” (“USDR” prior to November 4, 2024).
| B. | On May 14, 2026, the Company entered into the underwriting agreement (the “Underwriting Agreement”) with Maxim Group LLC, as representative of the several underwriters (the “Underwriters”) relating to the a public offering (the “Offering”) of 1,125,000 units, with each unit consisting of one share of Common Stock and warrants to purchase one share of Common Stock at an exercise price of $8.60 per share, exercisable for a period of five years, subject to certain adjustments and cashless exercise provisions. The combined price public offering price per unit was $8.20. Under the terms of the Underwriting Agreement, the Company granted the Underwriters an option, exercisable for 45 days following the closing of the Offering, to purchase up to an additional 168,750 shares of Common Stock and/or Warrants to purchase 168,750 shares of common stock to cover over-allotments, if any. On May 15, 2026, the Underwriter partially exercised its over-allotment option with respect to Warrants to purchase 168,750 shares of Common Stock. |
On May 18, 2026, the Company closed the Offering, as well as the partial exercise of the over-allotment option, and issued the Shares and Warrants, resulting in aggregate gross proceeds of approximately $9,225 thousands, before deducting underwriting discounts and commissions and estimated offering expenses. Concurrently with the closing of the Offering, the Company also issued warrants to purchase an aggregate of up to 90,000 shares of Common Stock to the representative of the Underwriters, with an exercise price of $10.25 per share (the “Representative’s Warrants”). The Representative’s Warrants are exercisable beginning on November 14, 2026, and expire on November 14, 2031, pursuant to the terms and conditions of the Representative’s Warrants.
On May 14, 2026, the Company’s Common Stock and Warrants were approved for listing on the Nasdaq Capital Market, and on May 15, 2026, the Common Stock and Warrants began trading on the Nasdaq Capital Market under the symbols “DUKR” and “DUKRW,” respectively.
| C. | Reverse stock split |
On August 12, 2025, the majority of the Company’s stockholders approved the Reverse Stock Split and on February 15, 2026, the Company’s Board of Directors approved a 25-for-1 reverse stock split (the “Reverse Stock Split”) of the Company’s issued and outstanding shares of Common Stock.
On March 4, 2026, the Company filed a Certificate of Amendment (the “Amendment”) to its Amended and Restated Certificate of Incorporation in Nevada to effect the Reverse Stock Split. The Amendment became effective on March 6, 2026.
As a result of the Reverse Stock Split, every 25 shares of the Company’s outstanding shares of Common Stock prior to the effect of the Amendment were combined and reclassified into one share of the Company’s Common Stock. No fractional shares were issued in connection with or following the reverse split and the shares were rounded to the nearest whole number. The authorized capital and par value of the Common Stock remained unchanged.
All shares, stock option and per share information in these consolidated financial statements have been restated to reflect the Reverse Stock Split on a retroactive basis.
| D. | Liquidity |
Since inception, the Company has incurred losses and negative cash flows from operations. The Company has financed its operations mainly through fundraising from various investors.
As described in Note 1B above, on May 18, 2026, the Company closed the Offering resulting in aggregate gross proceeds of approximately $9,225 and commencing May 15, 2026, the Company's Common Stock and Warrants began trading on the Nasdaq Capital Market. In light of the proceeds received from this fundraising, and based on the projected cash flows and cash balances as of the date of approval of these consolidated financial statements, management is of the opinion that the Company’s existing cash will be sufficient to meet its obligations for a period of more than 12 months from the date of approval of these consolidated financial statements.
| E. | In October 2023, a large-scale terrorist attack in southern Israel led to the outbreak of armed conflict between Israel and Hamas. The conflict subsequently expanded to additional regional fronts and contributed to a period of heightened geopolitical and security instability in the region. |
During 2024 and 2025, hostilities included military operations in Lebanon and direct confrontations involving Iran. These developments increased regional uncertainty and, at times, resulted in temporary disruptions to the Company’s operations in Israel, including limited interruptions to routine business activities.
In September 2025, a ceasefire agreement was reached between Israel and Hamas, and all remaining living Israeli hostages were released and returned to Israel. While the ceasefire has generally held as of the date of these financial statements, the security situation remains sensitive, and the potential for renewed hostilities or broader regional escalation cannot be ruled out. More recently, on February 28, 2026, hostilities between Israel and Iran escalated again. Israel, together with the United States, conducted a major joint military campaign of air and missile strikes against targets in Iran, which triggered a broad Iranian response and contributed to significant regional instability. The situation remains highly fluid, and we are unable to predict when, or on what terms, this escalation will be resolved. Accordingly, the extent of the continued impact on the Company’s operations and financial results, if any, cannot be reasonably estimated at this time.
Given that the majority of the Company’s operations are conducted in Israel, and that all members of the Company’s board of directors and management, as well as most employees, consultants, and service providers, are located in Israel, the Company is directly affected by the economic, political, geopolitical, and military conditions impacting the region. As of March 31, 2026, while ceasefire arrangements with Hamas, Lebanon and Iran were generally in effect and large-scale military operations had subsided, the overall security environment in Israel and the surrounding region remained unstable and unpredictable. The recent hostilities resulted in temporary disruptions to the Company’s operations, resulting in a decrease in revenues during certain periods in 2025, and may continue to have an adverse impact on certain business activities. Any further escalation or expansion of the conflict could negatively affect both regional and global conditions, and may adversely impact the Company’s business, financial condition, and results of operations.
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION
Basis of presentation
The accompanying unaudited condensed consolidated interim financial statements include the accounts of the Company and its subsidiaries, prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). In the opinion of management, the financial statements presented herein include all material adjustments (consisting of normal recurring adjustments) which are, in the opinion of the Company’s management, necessary for a fair statement of the financial condition, results of operations, changes in shareholders equity and cash flows for three-months ended March 31, 2026. However, these results are not necessarily indicative of results for any other interim period or for the year ended December 31, 2026. The preparation of financial statements in conformity with GAAP requires the Company to make certain estimates and assumptions for the reporting periods covered by the financial statements. These estimates and assumptions affect the reported amounts of assets, liabilities, revenues and expenses. Actual amounts could differ from these estimates
These financial statements should be read in conjunction with the audited financial statements included in the Company’s Form 10-K for the year ended December 31, 2025 as filed with the Securities and Exchange Commission. The Company’s significant accounting policies are disclosed in the audited financial statements for the year ended December 31, 2025 included in the Company’s Form 10-K. Since the date of such financial statements, there have been no changes to the Company’s significant accounting policies.
The accompanying unaudited condensed consolidated interim financial statements are prepared in accordance with GAAP. The unaudited condensed consolidated interim financial statements of the Company include the Company and its wholly-owned and majority-owned subsidiaries. All inter-company balances and transactions have been eliminated.
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION**(continued)**
Use of Estimates
The preparation of unaudited condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, certain revenues and expenses, and disclosure of contingent assets and liabilities as of the date of the financial statements. Actual results could differ from those estimates.
Fair Value Measurements
Fair value of certain of the Company’s financial instruments including cash, accounts receivable, account payable, accrued expenses, and other accrued liabilities approximate cost because of their short maturities. The Company measures and reports fair value in accordance with Accounting Standards Codification (“ASC”) 820, “Fair Value Measurements and Disclosure” (“ASC 820”) defines fair value, establishes a framework for measuring fair value in accordance with generally accepted accounting principles and expands disclosures about fair value investments.
Fair value, as defined in ASC 820, is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value of an asset should reflect its highest and best use by market participants, principal (or most advantageous) markets, and an in-use or an in-exchange valuation premise. The fair value of a liability should reflect the risk of non-performance, which includes, among other things, the Company’s credit risk.
Valuation techniques are generally classified into three categories: the market approach; the income approach; and the cost approach. The selection and application of one or more of the techniques may require significant judgment and are primarily dependent upon the characteristics of the asset or liability, and the quality and availability of inputs. Valuation techniques used to measure fair value under ASC 820 must maximize the use of observable inputs and minimize the use of unobservable inputs. ASC 820 also provides fair value hierarchy for inputs and resulting measurement as follows:
Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities.
Level 2: Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities; and
Level 3: Unobservable inputs for the asset or liability that are supported by little or no market activity, and that are significant to the fair values.
Fair value measurements are required to be disclosed by the Level within the fair value hierarchy in which the fair value measurements in their entirety fall. Fair value measurements using significant unobservable inputs (in Level 3 measurements) are subject to expanded disclosure requirements including a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings, and a description of where those gains or losses included in earning are reported in the statement of comprehensive loss.
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION**(continued)**
The Company’s financial liabilities that are measured at fair value on a recurring basis by level within the fair value hierarchy are as follows:
| Level 1 | Level 2 | Level 3 | Total | |
|---|---|---|---|---|
| US$ | ||||
| Stock purchase warrants liability | - | - | 708 | 708 |
| Total | - | - | 708 | 708 |
| Level 1 | Level 2 | Level 3 | Total | |
|---|---|---|---|---|
| US$ | ||||
| Stock purchase warrants liability | - | - | 189 | 189 |
| Total | - | - | 189 | 189 |
NOTE 3 – LEASES
| A. | On April 4, 2022, the Company signed a lease agreement for an office space in Mevo Carmel Science and Industry Park, Israel for a term of 3 years, with an option to extend the term of the lease agreement for an additional 2 years. The monthly lease payments under the lease agreement for the first two years are NIS 16.5 (approximately $4.6) and for the third year NIS 17.2 (approximately $4.8). The monthly lease payments for the option period will be agreed between the parties, with a minimum increase of 5% above the third year monthly payment. Lease payments are linked to the Israeli Consumer Price Index. The property became available for Company’s use in February 2023. Based on the lease agreement terms, the Company made a deposit of $15 as a guarantee for its lease commitments. The Company utilized the two year extension option under the above lease agreement. |
| B. | The components of operating lease expense for the period ended March 31, 2026 and 2025 were as follows: |
| Three months ended March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| Operating lease expense | 18 | 16 |
NOTE 3 – LEASES (continued)
| C. | Supplemental cash flow information related to operating leases was as follows: |
| Three months ended March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| Cash paid for amounts included in the measurement of lease liabilities: | ||
| Operating cash flows from operating leases | 19 | 16 |
| D. | Supplemental balance sheet information related to operating leases was as follows: |
| March 31, | December 31, | |
|---|---|---|
| 2026 | 2025 | |
| Operating leases: | ||
| Operating leases right-of-use asset and lease deposit | 114 | 127 |
| Current operating lease liabilities | 73 | 72 |
| Non-current operating lease liabilities | 47 | 63 |
| Total operating lease liabilities | 120 | 135 |
| Weighted average remaining lease term (years) | 1.84 | 2.08 |
| Weighted average discount rate | 8.75% | 8.75% |
| E. | Future minimum lease payments under non-cancellable leases as of March 31, 2026 were as follows: |
| 2026 | 57 |
| 2027 | 71 |
| 2028 | 1 |
| Total operating lease payments | 129 |
| Less: imputed interest | (9) |
| Present value of lease liabilities | 120 |
NOTE 4 – SHAREHOLDERS’ EQUITY
Transactions:
| A. | Following the reverse stock split effected on March 6, 2026 as detailed in note 1B above, the Company adjusted its number of outstanding shares of common stock as of December 31, 2025, to reflect the effect of additional 8,232 shares of common stock of the Company, issued to existing stockholders. |
| B. | On May 11, 2021, the Company entered into securities purchase agreements with eight (8) non-U.S. investors, pursuant to which the Company, in a private placement offering, agreed to issue and sell to the investors an aggregate of: (i) 500,000 shares of the Company’s common stock, at a price of $10 per share; and (ii) warrants (the “Warrants”) to purchase 500,000 Company’s common stock. |
On May 11, 2021, the Company entered into a service agreement with a non-U.S. third party for financial and project oversight services in connection with an offering. Under the agreement, the Company agreed to pay the service provider 6% of the investment amounts received, and options to receive units, each consisting of one share and one warrant exercisable at $10 per share, equal to 6% of the investment amount received divided by $10. In the event that the offering investors exercise their Warrants, the service provider is entitled to additional payments and options based on 6% of the investment and warrant exercise amounts received.
On March 10, 2026, the Company entered into a warrant amendment agreement with the existing Warrant (the “2021 Warrants Amendment”). According to the 2021 Warrants Amendment, the Company and Holders agreed to extend the warrant exercise term of the Warrants from May 11, 2026 to May 1, 2031.
The Company accounted for the 2021 Warrant Amendments as deemed dividends. The fair value of the Warrant modifications was estimated using the Black-Scholes option-pricing model and is presented within the consolidated statements of changes in shareholders equity as a credit to additional paid in capital and a debit to the accumulated deficit.
The following are the data and assumptions used:
| Dividend yield | 0 |
|---|---|
| Expected volatility (%) | 161.54% |
| Risk-free interest rate (%) | 3.73% |
| Contractual term of options (years) | 5.15-5.23 |
| Exercise price (US dollars) | 16.25 |
| Share price (US dollars) | 7 |
| Fair value (USD in thousands) | 3,941 |
| C. | On December 30, 2025, the Company entered into securities purchase agreements with seven non-U.S. investors, pursuant to which the Company issued and sold in a private placement offering an aggregate of 83,338 shares of common stock and warrants to purchase 83,338 shares of common stock. The warrants were exercisable immediately at an exercise price of $16.25 per share and were originally scheduled to expire on November 30, 2026, subject to extension to May 30, 2028 if a public offering or other qualifying financing of at least $2,500 had not occurred prior to such date. The securities purchase agreements also include a make-whole provision pursuant to which the investors may receive additional shares of common stock upon the occurrence of certain qualifying public offering events. The aggregate gross proceeds from the offering were approximately $750 of which $475 received in December 2025 and $275 received in January 2026. |
On March 10, 2026, the Company entered into the Warrant Amendment Agreement with the investors of the December 30, 2025 securities purchase agreement, pursuant to which the term of the warrants was extended such that they expire on May 1, 2031.
NOTE 4 – SHAREHOLDERS’ EQUITY (continued)
The Company analyzed the warrants, including the make-whole provision, in accordance with ASC 480, Distinguishing Liabilities from Equity, and ASC 815, Derivatives and Hedging, and concluded that the warrants do not meet the criteria for equity classification. The Company also concluded that the make-whole provision is not legally detachable and cannot be separately exercised and, therefore, is not a freestanding instrument. Accordingly, the warrants, inclusive of the make-whole provision, are accounted for as a single liability-classified instrument, initially recorded at fair value and remeasured at fair value at each reporting date, with changes in fair value recognized in the consolidated statements of operations until settlement or expiration.
Warrant liability
The fair value of warrants liability and the make-whole provision was calculated using a third-party specialist.
The calculations were based on the probability of the expected offering date, using the Black-Scholes option-pricing model and the make-whole provision was calculated using the Monte Carlo Simulation Model. The warrants liability was estimated at $708 and $189 as of March 31, 2026 and December 31, 2025, respectively and recorded as current liability on the balance sheet.
The assumptions used to perform the calculations are detailed below:
| March 31, 2026 | December 30, 2025 | |
|---|---|---|
| Expected volatility (%) | 84.31% - 146.92% | 127.44% - 179.34% |
| Risk-free interest rate (%) | 3.7% - 3.92% | 3.47% - 3.48% |
| Expected dividend yield | 0.0% | 0.0% |
| Expected term (years) | 0.173-5.086 | 0.316-2.417 |
| Conversion price (U.S. dollars) | 16.25 | 16.25 |
| Underlying share price (U.S. dollars) | 8.48 | 6.25 |
| Fair value (U.S. dollars in thousands) | 708 | 189 |
Fair Value Proportional Allocation
Based on the above, the fair value proportion allocation as of March 31, 2026 and December 31, 2025, respectively, was as follows:
| March 31, 2026 | December 31, 2025 | |
|---|---|---|
| Equity component | 451 | 286 |
| 2025 Warrants | 299 | 189 |
| Total | 750 | 475 |
NOTE 5 - SHARE BASED COMPENSATION
The following table presents the Company’s stock option activity the three months ended March 31, 2026:
| Number of Options | Weighted Average Exercise Price | |
|---|---|---|
| Outstanding at December 31, 2025 | 179,876 | 20.33 |
| Granted | 138,000 | 7.88 |
| Exercised | - | - |
| Forfeited or expired | - | - |
| Outstanding at March 31, 2026 | 317,876 | 11.00 |
| Number of options exercisable at March 31, 2026 | 124,678 | 16.99 |
The aggregate intrinsic value of the awards outstanding as of March 31, 2026 is $502. These amounts represent the total intrinsic value, based on the Company’s stock price of $8.48 as of March 31, 2026, less the weighted exercise price.
The stock options outstanding as of March 31, 2026, have been separated into exercise prices, as follows:
| Exercise price | Stock options outstanding | Weighted average remaining contractual life – years | Stock options exercisable |
|---|---|---|---|
| 0.0025 | 18,000 | 0.28 | 18,000 |
| 5.25 | 82,800 | 4.96 | 27,602 |
| 9.50 | 50,275 | 1.28 | 50,275 |
| 25.00 | 3,975 | 1.25 | 3,975 |
| 56.25 | 24,826 | 1.25 | 24,826 |
| 7.88 | 138,000 | 5.95 | - |
| 317,876 | 4.22 | 124,678 |
Compensation expense recorded by the Company in respect of its share-based compensation awards for the three months ended March 31, 2026 and 2025 were $95 and $10, respectively. These expenses are included in General and Administrative expenses in the Statements of Operations.
NOTE 6 – RELATED PARTIES
| A. | Transactions and balances with related parties |
| Three months ended March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| General and administrative expenses: | ||
| Directors and Officers compensation (*) | 207 | 120 |
| (*) Share base compensation | 47 | 5 |
| Financing: | ||
| Financing expense | 2 | 2 |
| B. | Balances with related parties: |
| As of March 31, | As of December 31, | |
|---|---|---|
| 2026 | 2025 | |
| Other accounts liabilities | 60 | 117 |
| Loans | 332 | 330 |
C. On March 10, 2026, the board of directors of the Company approved the issuance of options to purchase 138,000 shares of common stock to employees, directors and consultants pursuant to the Company’s 2021 Equity Incentive Plan (the “2021 Plan”) and in addition an increase in the number of shares of common stock available under the 2021 Plan from 360,000 to 480,000.
In addition, out of the options mentioned above, the board of directors approved the issuance of:
| Name | Position | Number of options |
|---|---|---|
| Mr. Yossef Balucka | Company’s CEO | 16,000 |
| Mr. Shlomo Zakai | Company’s CFO | 10,000 |
| Mr. Vadim Maor | Company’s CTO | 4,000 |
| Mr. Erez Nachtomy | Active chairman of the board of the Company | 16,000 |
| Ms. Keren Gousman Golan | Director of the Company | 4,000 |
| Mr. Eran Antebi | Director of the Company | 4,000 |
All such options are exercisable at an exercise price of $7.88 per share, vest in three equal annual installments of 33% at the end of each year, expire six years from the date of grant, and are subject to the other terms and conditions set forth in the 2021 Plan.
NOTE 7 – SEGMENT INFORMATION
The Company hasone operating and reportable segment, drone insulators washing activity.
The chief operating decision maker evaluates segment performance primarily based on segment operating loss.
The Company refined the name of the segment previously referred to as “Revenue from drones insulators washing” to “Revenues from civil applications segment” to better reflect its nature. The change had no impact on the composition or nature of the segment’s activities.
The following table presents information about the Company’s reportable segment for the three months ended March 31, 2026 and 2025:
Revenue related to the Company’s reportable segments is as follows:
| Three months ended | ||
|---|---|---|
| 2026 | 2025 | |
| Revenue from civil applications segment | - | - |
| Cost of revenues from civil applications segment | (33) | (8) |
| Gross loss | (33) | (8) |
| Research and development expenses | (29) | (22) |
| Depreciation | (2) | (13) |
| Professional services | (298) | (175) |
| Share base compensation | (95) | (10) |
| Other general and administrative expenses | (56) | (60) |
| Operating loss | (513) | (288) |
| Interest expenses | (443) | (30) |
| Interest income | 35 | 39 |
| Net loss | (921) | (279) |
For the three months ended March 31, 2026 and 2025, the Company’s operations were mostly confined to Israel. As of March 31, 2026 and 2025, all of the fixed assets of the Company were located in Israel and Greece.
NOTE 8 – SUBSEQUENT EVENTS
See Note 1B above regarding the public offering closed on May 18, 2026.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.